Additional impact of pancreatic juice cytology via endoscopic nasal pancreatic tube for the diagnosis of high-grade pancreatic intraepithelial neoplasia/ invasive pancreatic cancer without visible tumor by endoscopic ultrasound
Not Applicable
Recruiting
- Conditions
- high-grade pancreatic intraepithelial neoplasia/ invasive pancreatic cancer without visible tumor by endoscopic ultrasound
- Registration Number
- JPRN-UMIN000052193
- Lead Sponsor
- Oita San-ai Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 22
Inclusion Criteria
Not provided
Exclusion Criteria
First, PJC for the diagnosis of suspected intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia/carcinoma derive from IPMN was excluded because of the different nature of tumor. PJC for suspected PDAC with visible mass by EUS due to the failure diagnosis of EUS-FNAB was also excluded. Patients with PJC positive results who underwent imaging follow-up less than one year without surgical resection and patients with PJC negative results who underwent imaging follow-up less than five years without surgical resection were excluded as undiagnosed cases, considering the progress nature/period of HG-PanIN and invasive PDAC.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of sensitivity, spesificity, accuracy, and area under curve of pancreatic juice cytology via endoscopic nasal pancreatic tube and those of single pancreatic juice cytology during endoscopic retrograde pancreatography.
- Secondary Outcome Measures
Name Time Method